Wellorithm’s GLP-1 Menu Decoded: Compounded vs Brand-Name, and What the Guarantee Really Covers

Choosing a GLP-1 program increasingly means navigating a two-tier world: compounded medications at accessible prices, and brand-name drugs at eye-watering ones. Wellorithm is one of the few telehealth programs that puts both tiers on the same menu with visible prices — which makes it an unusually useful case study in what GLP-1 therapy actually costs in 2026.

We’ve previously reviewed Wellorithm’s data-driven care approach; this piece focuses on the money and the promises: the full medication menu, the weight-loss guarantee, and how its obesity-specialist model frames the value.

The full menu, with real numbers

Wellorithm’s published options at the time of review:

• Compounded semaglutide (injection or tablets): from $147/month
• Compounded tirzepatide (injection or tablets): from $249/month
• Brand-name: Wegovy from $899, Ozempic from $1,199, Mounjaro from $1,399, Zepbound from $1,199
• Add-ons: NAD+ and Sermorelin at $150 each

That brand-vs-compounded gap — roughly $750-1,250 a month — is the entire GLP-1 affordability story in one table. Wellorithm currently sweetens the entry point with a promotional first month around $147, a $100 first-month discount and free shipping, plus HSA/FSA eligibility and no membership fees.

What the guarantee actually means

Wellorithm advertises a weight-loss guarantee — a bold promise in a field where individual response varies enormously. Guarantees like this are typically conditional: staying on protocol, completing check-ins, meeting adherence requirements. We couldn’t audit every term from the outside, so our advice is practical: before enrolling, ask support for the guarantee’s exact conditions in writing. A guarantee you understand is a real benefit; one you assume is a future dispute.

The clinical model behind the menu

Under the pricing sits a genuinely credentialed structure: board-certified obesity-medicine specialists, unlimited 24/7 support, virtual consultations and ongoing coaching, available across 49 US states. Wellorithm cites internal figures like 93% patient retention and markets GLP-1 therapy’s well-documented advantage over lifestyle change alone (its ‘6x more weight loss than diet and exercise’ claim tracks the direction of published clinical trials, though individual results vary widely). Tablet options for both semaglutide and tirzepatide are a practical differentiator for the needle-averse.

How it stacks up

Against budget compounders, Wellorithm’s from-$147 semaglutide is competitive but not the floor — commitment-based rivals dip under $100. Against premium coaching programs, its obesity-specialist involvement at mid-market prices is strong value. And for the minority who specifically want brand-name medication through a telehealth wrapper, having Wegovy, Ozempic, Mounjaro and Zepbound on a transparent menu is rare and useful.

Compounded vs brand-name: how to actually choose

Wellorithm’s dual menu forces a decision most services hide, so here’s a framework. Brand-name drugs (Wegovy, Zepbound et al.) are FDA-approved finished products with manufacturing consistency guaranteed at the factory level — the medically conservative choice if the $899-1,399 monthly cost is viable, or if insurance covers part of it. Compounded versions deliver the same active-ingredient class at roughly one-fifth to one-tenth the price, prepared per-prescription by licensed pharmacies but without finished-product FDA approval. For most cash-paying patients, compounded is the only economically sustainable route for the year-plus these therapies typically run — which is exactly why the category exists.

Two practical notes: insurance occasionally covers brand-name GLP-1s for qualifying patients (worth checking before defaulting to cash pricing), and switching tiers mid-program is a conversation Wellorithm’s obesity specialists can manage — another advantage of a menu that carries both.

Enrollment walkthrough

The path runs: online evaluation, licensed-professional review, prescription where appropriate, home delivery. Before you commit, do three things — confirm your dose-escalation price trajectory (does ‘from $147’ hold at maintenance doses?), obtain the weight-loss guarantee’s written terms, and verify availability in your state (Wellorithm covers 49). The intake takes minutes; the diligence takes ten more and prevents every common billing surprise in this category.

Safety context

GLP-1 therapy carries standard exclusions — medullary thyroid carcinoma history, MEN 2, prior pancreatitis, pregnancy — and common early side effects (nausea, digestive upset) that typically fade with careful titration. Wellorithm’s board-certified obesity specialists and 24/7 support are well-suited to managing exactly these; use them. Marketing claims like ‘6x more weight loss than diet and exercise’ directionally match trial literature but describe averages, not promises. This review is information, not medical advice.

Pros and cons

What we liked

• Transparent two-tier menu spanning compounded and brand-name options
• Board-certified obesity specialists with 24/7 support
• Tablet alternatives to injections
• HSA/FSA eligibility, no membership fees, 49-state coverage

What to weigh

• Not the cheapest compounded option on the market
• Guarantee terms require careful reading
• Marketing statistics are internal figures — treat as directional

Our verdict

Wellorithm’s greatest service might be clarity: it shows the whole GLP-1 cost landscape on one page and staffs the program with real obesity-medicine specialists. If you want that clinical depth with mid-market pricing — or a rare transparent path to brand-name drugs — it’s a strong candidate. Read the guarantee’s fine print, and you’ll know exactly what you’re buying.

Frequently asked questions

How much does Wellorithm cost?

Compounded semaglutide from $147/month and tirzepatide from $249/month; brand-name options run $899-1,399/month. HSA/FSA eligible with no membership fees.

Does Wellorithm offer pills instead of injections?

Yes — both semaglutide and tirzepatide are available as tablets as well as injections, a useful option for the needle-averse.

Is the weight-loss guarantee unconditional?

Assume it isn’t — such guarantees typically carry adherence conditions. Request the exact written terms from support before enrolling.

Where is Wellorithm available?

The program covers 49 US states with virtual consultations, board-certified obesity specialists, unlimited 24/7 support and home delivery, so most US residents can enroll — confirm your state during the online evaluation.